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A B S T R A C T
Background: The World Health Organization (WHO) and the International Labour Organization (ILO) are developing a joint methodology for estimating the national
and global work-related burden of disease and injury (WHO/ILO joint methodology), with contributions from a large network of experts. Here, we present the
protocol for two systematic reviews of parameters for estimating the number of disability-adjusted life years of cataracts from occupational exposure to solar
ultraviolet radiation, to inform the development of the WHO/ILO joint methodology.
Objectives: We aim to systematically review studies on occupational exposure to solar ultraviolet radiation (Systematic Review 1) and systematically review and
meta-analyse estimates of the effect of occupational exposure to solar ultraviolet radiation on the development of cataract (Systematic Review 2), applying the
Navigation Guide systematic review methodology as an organizing framework and conducting both systematic reviews in tandem and in a harmonized way.
Data sources: Separately for Systematic Reviews 1 and 2, we will search electronic academic databases for potentially relevant records from published and un-
published studies, including Ovid Medline, PubMed, EMBASE, and Web of Sciences. We will also search electronic grey literature databases, Internet search engines
and organizational websites; hand search reference list of previous systematic reviews and included study records; and consult additional experts.
Study eligibility and criteria: We will include working-age (≥15 years) workers in WHO and/or ILO Member States, but exclude children (< 15 years) and unpaid
domestic workers. For Systematic Review 1, we will include quantitative studies on the prevalence of relevant levels of occupational exposure to solar ultraviolet
radiation and of the total working time spent outdoors from 1960 to 2018, stratified by sex, age, country and industrial sector or occupation. For Systematic Review
2, we will include randomized controlled trials, cohort studies, case-control studies and other non-randomized intervention studies with an estimate of the effect of
any occupational exposure to solar ultraviolet radiation (i.e. ≥30 Jm−2/day of occupational solar UV exposure at the surface of the eye) on the prevalence or
incidence of cataract, compared with the theoretical minimum risk exposure level (i.e.< 30 Jm−2/day of occupational solar UV exposure at the surface of the eye).
Study appraisal and synthesis methods: At least two review authors will independently screen titles and abstracts against the eligibility criteria at a first stage and full
texts of potentially eligible records at a second stage, followed by extraction of data from qualifying studies. At least two review authors will assess risk of bias and the
quality of evidence, using the most suited tools currently available. For Systematic Review 2, if feasible, we will combine relative risks using meta-analysis. We will
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report results using the guidelines for accurate and transparent health estimates reporting (GATHER) for Systematic Review 1 and the preferred reporting items for
systematic reviews and meta-analyses guidelines (PRISMA) for Systematic Review 2.
PROSPERO registration: CRD42018098897.
1. Background
The World Health Organization (WHO) and the International
Labour Organization (ILO) are developing a joint methodology for es-
timating the work-related burden of disease and injury (WHO/ILO joint
methodology) (Ryder, 2017). The organizations plan to estimate the
numbers of deaths and disability-adjusted life years (DALYs) that are
attributable to selected occupational risk factors, in the first place for
the year 2015. The WHO/ILO joint methodology will be based on al-
ready existing WHO and ILO methodologies for estimating the burden
of disease for selected occupational risk factors (International Labour
Office, 2014; Prüss-Üstün et al., 2017). It will expand existing meth-
odologies with estimation of the burden of several prioritized additional
pairs of occupational risk factors and health outcomes. For this purpose,
population attributable fractions (Murray et al., 2004) – the propor-
tional reduction in burden from the health outcome achieved by a re-
duction of exposure to the risk factor to zero – will be calculated for
each additional risk factor-outcome pair, and these fractions will be
applied to the total disease burden envelopes for the health outcome
from the WHO Global Health Estimates (World Health Organization,
2017).
The WHO/ILO joint methodology may include a methodology for
estimating the burden of cataracts from occupational exposure to solar
ultraviolet (UV) radiation (UVR), if feasible, as one additional prior-
itized risk factor-outcome pair. To optimize parameters used in esti-
mation models, a systematic review is required of studies on the pre-
valence of exposure to solar UVR (‘Systematic Review 1’), as well as a
second systematic review and meta-analysis of studies with estimates of
the effect of exposure to solar UVR on cataract (‘Systematic Review 2’).
In the current paper, we present the protocol for this systematic review
and meta-analysis, in parallel to presenting systematic review protocols
on other additional risk factor-outcome pairs elsewhere (Descatha et al.,
2018; Godderis et al., 2018; Hulshof et al., for publication; Li et al.,
2018; Mandrioli et al., 2018; Paulo et al., for publication; Rugulies
et al., Accepted; Teixeira et al., for publication). To our knowledge, this
is the first systematic review protocol of its kind. The WHO/ILO joint
estimation methodology and the burden of disease estimates are sepa-
rate from these systematic reviews, and they will be described and re-
ported elsewhere.
We refer separately to Systematic Reviews 1 and 2, because the two
systematic reviews address different objectives and therefore require
different methodologies. The two systematic reviews will, however, be
harmonized and conducted in tandem. This will ensure that – in the
later development of the methodology for estimating the burden of
disease from this risk factor–outcome pair – the parameters on the risk
factor prevalence are optimally matched with the parameters from
studies on the effect of the risk factor on the designated outcome. The
findings from Systematic Reviews 1 and 2 will be reported in two dis-
tinct journal articles. For this protocol and another protocol in the series
Paulo et al. (for publication) with occupational exposure to solar UVR
as the risk factor, one Systematic Review 1 will be published.
1.1. Rationale
Cataract is the leading cause of blindness and an important cause of
low vision globally (World Health Organization, undated), with in-
cidence of age-related cataract expected to increase. Exposure to UVR is
a recognized risk factor for developing cataract (McCarty and Taylor,
2002; Yam and Kwok, 2014), and outdoor work is one of the main
determinants of individual long-term solar UVR exposure, with farmers
and construction workers, for example, spending the majority of their
time working outdoors (Kimlin and Tenkate, 2007).
In 2006, WHO published global health estimates of the total burden
of disease due to solar radiation exposure, estimating loss of 529,242
DALYs globally from cataract attributable to UVR (Lucas et al., 2006).
These estimates only covered cortical cataract, but some data suggest
an increased incidence also of both posterior subcapsular and nuclear
cataract in geographic areas receiving high ambient UVR exposure. A
latitudinal gradient for an increasing proportion of cortical cataract
among all cataracts was observed, with higher proportions of cortical
cataract at lower latitudes.
To consider the feasibility of estimating the burden of cataracts from
occupational exposure to solar UVR, and to ensure that potential esti-
mates of burden of disease are reported in adherence with the guide-
lines for accurate and transparent health estimates reporting (GATHER)
(Stevens et al., 2016), WHO and ILO require a systematic review of
studies on the prevalence of relevant levels of occupational exposure to
solar UVR (Systematic Review 1), as well as a second systematic review
and meta-analysis of studies with estimates of the relative effect of
occupational exposure to solar UVR on cataracts, compared with the
theoretical minimum risk exposure level (Systematic Review 2). The
theoretical minimum risk exposure level is the exposure level that
would result in the lowest possible population risk, even if it is not
feasible to attain this exposure level in practice (Murray et al., 2004).
These prevalence and effect estimates should be tailored to serve as
parameters for estimating the burden of cataracts from occupational
solar UVR in the WHO/ILO joint methodology. Even though there have
been recent systematic reviews of the global burden of eye and vision
disease (Boyers et al., 2015) and the global prevalence of blindness and
vison impairment (Bourne et al., 2017), to our knowledge, this is the
first systematic review that will provide a comprehensive evidence base
for estimating the occupational burden of cataracts.
Previous reviews examining the relationship between UVR exposure
and cataracts in humans have found a significant association between
UV-B exposure and the development of cortical cataract and possibly
posterior subcapsular cataract, with some studies demonstrating a dose-
response relationship between UV-B exposure and cataracts. However,
less than half of the studies reviewed specifically assessed occupational
exposure to UVR (McCarty and Taylor, 2002; Yam and Kwok, 2014).
The most recent systematic review only considered studies of occupa-
tional exposure to solar radiation (Modenese and Gobba, 2018). A total
of 15 studies were found, 12 of which showed a positive association
between cataract (any subtype) and UVR exposure related to outdoor
work. Appendix A provides further discussion of these reviews and
design limitations identified in the studies reviewed.
Regarding Systematic Review 1, we are not aware of a previous
systematic review of occupational exposure to solar UVR. Systematic
Review 2 will be different to the previous systematic reviews sum-
marized above in that it will have a specific focus on occupational ex-
posure to solar UV, will have a broader timeframe for inclusion of
studies and will be undertaken with more consistent and rigorous sys-
tematic review methods, which includes the preparation of this pro-
tocol.
1.2. Description of the risk factor
The definition of the risk factor, the risk factor levels and the the-
oretical minimum risk exposure level are presented in Table 1. Ultra-
violet radiation is part of the spectrum of electromagnetic radiation
emitted by the sun and is arbitrarily divided into three bands of
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different wavelengths: UV-A 400–315 nm, UV-B 315–280 nm, and UV-C
280–100 nm (Lucas et al., 2006). However, the exact wavelength at
which divisions are constructed differ for different disciplines.
Artificial sources of UVR (e.g. lamps, welding) can include all UV
bands (UV-A, UV-B, and UV-C) whereas terrestrial solar UVR only
contains UV-A and UV-B bands. Ultraviolet radiation in band C
(280–100 nm) is totally filtered within the ozone layer, which also
absorbs the majority (~90%) of UV-B, while UV-A passes through the
atmosphere with little change (Roy et al., 1998). While all three types
of UVR have differing effects on humans, when humans are exposed to
sunlight, it is UV-A and UV-B which are primarily responsible for health
effects on the skin and eye.
For solar UVR exposure to the eye, the following factors are im-
portant (McCarty et al., 1997; Taylor, 1994): (1) the ambient UVR level
in the environment; (2) the amount of time an individual spends out-
doors, which for outdoor workers is particularly associated with work
tasks; (3) the ocular-ambient exposure ratio (i.e. the proportion of
ambient UVR which actually reaches the eye); and (4) the use of ocular
protection such as hats and sunglasses.
For occupational exposure, the most widely used UVR exposure
limit was initially developed by the American Conference of
Governmental Industrial Hygienists (ACGIH) and has been adopted
internationally by the International Commission on Non-Ionizing
Radiation Protection (ICNIRP). This standard/limit is based on
threshold data (i.e. the minimum exposure needed to produce a specific
biological effect) for erythema and photokeratitis, which are both acute
effects. It describes ‘allowed’ daily (i.e. 8 h) exposure at each wave-
length in the UV spectrum (i.e. the so-called ‘UV Hazard Curve’), with
the lowest (or limiting) dose being 30 Jm−2 at 270 nm (ACGIH, 2017).
For the purposes of this review, we will determine ocular solar UVR
exposure by applying an ocular-ambient exposure ratio to the best
available exposure data. This data primarily comes from personal do-
simetry studies where workers have worn UV dosimeters/measurement
devices for different time periods or work shifts, with the most com-
prehensive database of exposures currently provided by the GENESIS-
UV project in Germany (IFA, undated). Further details on solar UV
exposure factors and our proposed approach are described in Appendix
A.
If quantitative estimates of solar UVR are available, workers will be
categorized into dichotomous exposure groups based on whether they
exceed the exposure limit: ‘exposed’ (i.e. ≥30 Jm−2) or ‘unexposed’
(i.e.< 30 Jm−2). However, if quantitative estimates of solar UVR are
not available, then workers will be categorized into dichotomous ex-
posure groups based on whether they are exposed to any occupational
solar UVR (i.e. exposed) or no occupational exposure to solar UVR (i.e.
unexposed). In this case, our protocol will be updated to reflect new
analyses.
Regarding the theoretical minimum risk exposure level, because of
the ubiquitous nature of solar UVR, it is one of the few occupational
exposures that everyone is exposed to. However, ongoing or regular
exposure at or below the ACGIH/ICNIRP exposure standard/guideline
for UVR is considered to produce an extremely small or undetectable
risk for the development of chronic health effects, including cataracts
(International Commission on Non-Ionizing Radiation Protection,
2010). As such, for the purposes of this review, we consider the ACGIH/
ICNIRP exposure standard to provide the theoretical minimum risk
exposure level for occupational solar UV exposure at the surface of the
eye.
Since the theoretical minimum risk exposure level is usually set
empirically based on the causal epidemiological evidence, we will
change the assumed level as evidence suggests. If a considerable
number of studies report risk factor levels or reference group levels that
are different from those definitions we describe here, then, if possible,
we will convert the studies to common measures and, if not possible, we
will report analyses on these alternate levels as supplementary material.
1.3. Description of the outcome
Cataract is clouding of the lens of the eye which prevents clear vi-
sion (World Health Organization, undated). It is a leading world-wide
cause of visual impairment and is responsible for half of all blindness,
approximately 20 million cases (Pascolini and Mariotti, 2012). The
three most common forms of cataract are: nuclear cataract, cortical
cataract and posterior subcapsular cataract (Thylefors et al., 2002). The
WHO Global Health Estimates group outcomes into standard burden of
disease categories (World Health Organization, 2017), based on stan-
dard codes from the International Statistical Classification of Diseases and
Related Health Problems 10th Revision (ICD-10) (World Health
Organization, 2015). The relevant WHO Global Health Estimates cate-
gory for this systematic review is “II.G.2. Cataracts”. In line with the
WHO Global Health Estimates, we define the health outcome covered in
Systematic Review 2 as cataracts, defined as conditions with ICD-10
codes “H25: Senile cataract” and “H26: Other cataract”. We will consider
prevalence and incidence of cataract. Systematic Review 2 covers the
entire relevant WHO Global Health Estimates category.
1.4. How the risk factor may impact the outcome
Fig. 1 presents the logic model for our systematic review of the
causal relationship between occupational exposure to solar UVR and
cataracts. This logic model is an a priori, process-orientated one
(Rehfuess et al., 2017) that seeks to capture the complexity of the risk
factor-outcome causal relationship (Anderson et al., 2011).
Mechanistic or experimental evidence suggests that UVR induces
cataract through photo-oxidation and inflammatory response pathways
as well as through causing DNA damage. Animal studies also support a
causal effect of UVR in the development of cataract. In addition, epi-
demiological studies have shown strong support for an association be-
tween personal solar UVR exposure and the development of cortical
cataracts. An overview of the evidence for the role of UVR in the de-
velopment of cataracts is provided in Appendix A.
2. Objectives
1. Systematic Review 1: To systematically review quantitative studies
of any design on the prevalence of relevant levels of occupational
exposure to solar UVR in the years 1960 to 2018 among working-
age workers, disaggregated by country, sex, year, age and industrial
sector or occupation.
2. Systematic Review 2: To systematically review and meta-analyse
Table 1
Definitions of the risk factor, risk factor levels and the minimum risk exposure level.
Concept Definition
Risk factor UV-A and UV-B from solar radiation exposure reaching the eye of workers
Risk factor levels The occupational exposure limit for UVR of direct exposure to the eye is recognized as being < 30 Jm−2/day (spectrally weighted to
the ‘UV Hazard Curve’) for an 8-hour workday and 40-hour workweek. Therefore, there will be two risk factor levels:
1. < 30 Jm−2/8-hour workday of occupational solar UV exposure at the surface of the eye
2. ≥30 Jm−2/8-hour workday of occupational solar UV exposure at the surface of the eye
Theoretical minimum risk exposure level < 30 Jm−2/8-hour workday of occupational solar UV exposure at the surface of the eye
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randomized controlled trials, cohort studies, case-control studies
and other non-randomized intervention studies with estimates of the
relative effect of a relevant level of occupational exposure to solar
UVR on cataracts in any year among working-age workers, com-
pared with the minimum risk exposure level.
3. Methods
We will apply the Navigation Guide (Woodruff and Sutton, 2014)
methodology for systematic reviews in environmental and occupational
health as our guiding methodological framework, wherever feasible.
The guide applies established systematic review methods from clinical
medicine, including standard Cochrane Collaboration methods for
systematic reviews of interventions, to the field of environmental and
occupational health to ensure systematic and rigorous evidence synth-
esis on environmental and occupational risk factors that reduces bias
and maximizes transparency (Woodruff and Sutton, 2014). The need for
further methodological development and refinement of the relatively
novel Navigation Guide has been acknowledged (Woodruff and Sutton,
2014).
Systematic Review 1 may not map well to the Navigation Guide
framework (Fig. 1 on page 1009 in (Lam et al., 2016c)), which is tai-
lored to hazard identification and risk assessment. Nevertheless, steps
1–6 for the stream on human data can be applied to systematically
review exposure to risk factors. Systematic Review 2 maps more closely
to the Navigation Guide framework, and we will conduct steps 1–6 for
the stream on human data, but not conduct any steps for the stream on
non-human data, although we will briefly summarize narratively the
evidence from non-human data that we are aware of.
We have registered the protocol in PROSPERO under
CRD42018098897. This protocol adheres with the preferred reporting
items for systematic review and meta-analysis protocols statement
(PRISMA-P) (Moher et al., 2015; Shamseer et al., 2015), with the ab-
stract adhering with the reporting items for systematic reviews in
journal and conference abstracts (PRISMA-A) (Beller et al., 2013). Any
modification of the methods stated in the present protocol will be re-
gistered in PROSPERO and reported in the systematic review itself.
Systematic Review 1 will be reported according to the GATHER
guidelines (Stevens et al., 2016), and Systematic Review 2 will be re-
ported according to the preferred reporting items for systematic review
and meta-analysis statement (PRISMA) (Liberati et al., 2009). Our re-
porting of the parameters for estimating the burden of cataracts from
occupational exposure to solar UVR in the systematic reviews will ad-
here with the requirements of the GATHER guidelines (Stevens et al.,
2016), because the WHO/ILO burden of disease estimates that may be
produced consecutive to the systematic reviews must also adhere to
these reporting guidelines.
Fig. 1. Logic model of the possible causal relationship between occupational exposure to solar UVR and cataract.
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3.1. Systematic Review 1
3.1.1. Eligibility criteria
The population, exposure, comparator and outcome (PECO) criteria
(Liberati et al., 2009) are described below.
3.1.1.1. Types of populations. We will include studies of working-age
(≥15 years) workers in the formal and informal economy. Studies of
children (aged< 15 years) and unpaid domestic workers will be
excluded. Participants residing in any WHO and/or ILO Member State
and any industrial setting or occupation will be included. Appendix B
provides a complete, but briefer overview of the PECO criteria.
3.1.1.2. Types of exposures. We will include studies that define
occupational exposure to solar UVR in accordance with our standard
definition (Table 1). Cumulative exposure may be the most relevant
exposure metric in theory, but we will here also prioritize a non-
cumulative exposure metric in practice, because we believe that global
exposure data on agreed cumulative exposure measures do not
currently exist. We will include all studies where occupational
exposure is measured, whether objectively (e.g. by means of
dosimeters), or subjectively, including studies that used
measurements by experts (e.g. scientists with subject matter
expertise) and self-reports by the worker or workplace administrator
or manager. If a study presents both objective and subjective
measurements, then we will prioritize objective measurements. We
will include studies with measures from any data source, including
registry data.
We will include studies on the prevalence of occupational exposure
to the risk factor, if it is disaggregated by country (defined as a WHO or
ILO Member State), sex (two categories: female, male), age (ideally in
5-year age bands, such as 20–24 years) (and, if possible, also skin type
[e.g. Fitzpatrick scale or colour]) and industrial sector (e.g.,
International Standard Industrial Classification of All Economic Activities,
Revision 4 [ISIC Rev. 4]) (United Nations, 2008) or occupational group
(as defined, for example, by the International Standard Classification of
Occupations 2008 [ISCO-08]) (International Labour Office, 2012).
Criteria may be revised in order to identify optimal data disaggregation
to enable subsequent estimation of the burden of disease.
We shall include studies with exposure prevalence data from 1
January 1960 until 31 July 2018. For optimal modelling of exposure,
WHO and ILO require exposure data up to 2018, because recent data
points help better estimate time trends, especially where data points
may be sparse. The additional rationale for this data collection window
is that the WHO and ILO aim to estimate burden of disease in the year
2015, and we believe that the lag time from exposure to outcome will
not exceed 55 years; so in their models, the organizations can use the
exposure data from as early as 1960 to determine the burden of cat-
aracts 55 years later in 2015. To make a conclusive judgment on the
best lag time to apply in the model, we will summarize the existing
body of evidence on the lag time between exposure to solar UVR and
cataracts in the review. The exposure parameter should match the one
used in Systematic Review 2 or can be converted to match it.
3.1.1.3. Types of comparators. There will be no comparator, because we
will review risk factor prevalence only.
3.1.1.4. Types of outcomes. Occupational exposure to solar UVR.
3.1.1.5. Types of studies. This systematic review will include
quantitative studies of any design, including cross-sectional studies.
These studies must be representative of the relevant industrial sector,
relevant occupation or the national population. We will exclude
qualitative, modelling and case studies, as well as non-original studies
without quantitative data (e.g. letters, commentaries and perspectives).
Study records written in any language will be included. If a study
record is written in a language other than those spoken by the authors
of this review or those of other reviews (Descatha et al., 2018; Hulshof
et al., for publication; Paulo et al., for publication; Li et al., 2018;
Mandrioli et al., 2018; Godderis et al., 2018; Rugulies et al., Accepted;
Teixeira et al., for publication) in the series (i.e. Arabic, Bulgarian,
Chinese, Danish, Dutch, English, French, Finnish, German, Hungarian,
Italian, Japanese, Norwegian, Portuguese, Russian, Spanish, Swedish
and Thai), it will be translated into English. Published and unpublished
studies will be included.
Studies conducted using unethical practices will be excluded from
the review.
3.1.1.6. Types of effect measures. We will include studies with a
measure of the prevalence of occupational exposure to solar UVR.
3.1.2. Information sources and search
3.1.2.1. Electronic academic databases. We (AM and MSP) will at a
minimum search the following four electronic academic databases:
1. Ovid MEDLINE with Daily Update (1 January 1960 to 31 July
2018).
2. PubMed (1 January 1960 to 31 July 2018).
3. EMBASE (1 January 1960 to 31 July 2018).
4. Web of Science (1 January 1960 to 31 July 2018) with inclusion of 3
databases: Science Citation Index Expanded; Social Sciences Citation
Index; and Arts and Humanities Citation Index.
The Ovid Medline search strategy for Systematic Review 1 is pre-
sented in Appendix C. We have tested and validated the search strategy
for the four selected databases. The CISDOC and TOXNET databases
were also tested, but their scopes were found to not sufficiently cover
that of the systematic review. We will perform searches in electronic
databases operated in the English language using a search strategy in
the English language. Consequently, study records that do not report
essential information (i.e. title and abstract) in English will not be
captured. We will adapt the search syntax to suit the other electronic
academic and grey literature databases. When we are nearing com-
pletion of the review, we will search the PubMed database for the most
recent publications (e.g., e-publications ahead of print) over the last six
months. Any deviation from the proposed search strategy in the actual
search strategy will be documented.
3.1.2.2. Electronic grey literature databases. We (AM and MSP) will at a
minimum search the following two electronic grey literature databases:
1. OpenGrey (http://www.opengrey.eu/).
2. Grey Literature Report (http://greylit.org/).
3.1.2.3. Internet search engines. We (AM and MSP) will also search the
Google (www.google.com/) and GoogleScholar (www.google.com/
scholar/) Internet search engines and screen the first 100 hits for
potentially relevant records, as has been done previously in Cochrane
Reviews (Pega et al., 2015; Pega et al., 2017).
3.1.2.4. Organizational websites. The websites of the seven following
international organizations and national government departments will
be searched by AM and MSP:
1. International Labour Organization (www.ilo.org/).
2. World Health Organization (www.who.int).
3. European Agency for Safety and Health at Work (https://osha.
europa.eu/en).
4. Eurostat (www.ec.europa.eu/eurostat/web/main/home).
5. China National Knowledge Infrastructure (http://www.cnki.net/).
6. Finnish Institute of Occupational Health (https://www.ttl.fi/en/).
7. National Institute of Occupational Safety and Health (NIOSH) of the
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United States of America, using the NIOSH data and statistics
gateway (https://www.cdc.gov/niosh/data/).
3.1.2.5. Hand-searching and expert consultation. We (AM and MSP) will
hand-search for potentially eligible studies in:
• Reference lists of previous systematic reviews.• Reference lists of all study records of all included studies.• Study records published over the past 24months in the three peer-
reviewed academic journals from which we obtain the largest
number of included studies.• Study records that have cited an included study record (identified in
Web of Science citation database).• Collections of the review authors.
Additional experts will be contacted with a list of included studies
and study records, with the request to identify potentially eligible ad-
ditional ones.
3.1.3. Study selection
Study selection will be carried out with Covidence (Babineau, 2014;
Covidence systematic review software). All study records identified in
the search will be downloaded, and duplicates will be identified and
deleted. Afterwards, at least two review authors (AM and MSP) will
independently screen against eligibility criteria titles and abstracts (step
1) and then full texts of potentially relevant records (step 2). A third
review author (CEP or TT) will resolve any disagreements between the
study selectors. If a study record identified in the literature search was
authored by a review author assigned to study selection or if an as-
signed review author was involved in the study, then the record will be
re-assigned to another review author for study selection. In the sys-
tematic review, we will document the study selection in a flow chart, as
per GATHER guidelines (Stevens et al., 2016).
3.1.4. Data extraction and data items
A data extraction form will be developed and piloted until there is
convergence and agreement among data extractors. At a minimum, two
review authors (out of: SB, AM, CEP and MSP) will independently ex-
tract the data on occupational exposure to solar UVR, disaggregated by
country, sex, age and industrial sector or occupation. A third review
author (SMJ, TL or TT) will resolve conflicting extractions. At a
minimum, we will extract data on study characteristics (including study
authors, study year, study country, participants and risk factor ex-
posure), study design (including study type and measurements of the
risk factor and response rate), risk of bias (including missing data, as
indicated by response rate and other measures) and study context. The
estimates of the proportion of the population exposed to the occupa-
tional risk factor from included studies will be entered into and man-
aged with, the Review Manager, Version 5.3 (RevMan 5.3) (2014) or
DistillerSR (EvidencePartner, 2017) softwares.
We will also extract data on potential conflict of interest in included
studies, including the financial disclosures and funding sources of each
author and their affiliated organization. We will use a modification of a
previous method to identify and assess undisclosed financial interests
(Forsyth et al., 2014). Where no financial disclosure/conflict of interest
is provided, we will search declarations of interest both in other records
from this study published in the 36months prior to the included study
record and in other publicly available repositories (Drazen et al., 2010a;
Drazen et al., 2010b).
We will request missing data from the principal study author by
email or phone, using the contact details provided in the principal study
record. If no response is received, we will follow up twice via email, at
two and four weeks.
3.1.5. Risk of bias assessment
Generally agreed methods (i.e. framework plus tool) for assessing
risk of bias do not exist for systematic reviews: of input data for health
estimates (The GATHER Working Group, 2016), for burden of disease
studies, of prevalence studies in general (Munn et al., 2014) and of
prevalence studies of occupational and/or environmental risk factors
specifically (Krauth et al., 2013; Mandrioli and Silbergeld, 2016;
Vandenberg et al., 2016). None of the five standard risk of bias as-
sessment methods in systematic reviews for occupational and/or en-
vironmental health (Rooney et al., 2016) are applicable to assessing
prevalence studies. The Navigation Guide does not support checklist
approaches, such as (Hoy et al., 2012; Munn et al., 2014), for assessing
risk of bias in prevalence studies.
We will use a modified version of the Navigation Guide risk of bias
tool (Lam et al., 2016c) that we developed specifically for Systematic
Review 1 (Appendix D). We will assess risk of bias on the levels of the
individual study and the entire body of evidence. As per our pre-
liminary tool, we will assess risk of bias along five domains: (i) selection
bias; (ii) performance bias; (iii) misclassification bias; (iv) conflict of
interest; and (v) other biases. Risk of bias will be: “low”; “probably
low”; “probably high”; “high” or “not applicable”. To judge the risk of
bias in each domain, we will apply our a priori instructions (Appendix
D).
All risk of bias assessors (CA, AG, FG, SMJ, TL, AM, MSP, TT and
MW) will trial the tool until they synchronize their understanding and
application of each risk of bias domain, considerations and criteria for
ratings. At least two study authors (AM and MSP) will then in-
dependently judge the risk of bias for each study by outcome, and a
third author (CA, AG, FG, SMJ, TL, TT or MW) will resolve any con-
flicting judgments. We will present the findings of our risk of bias as-
sessment for each eligible study in a standard ‘Risk of bias’ table
(Higgins et al., 2011). Our risk of bias assessment for the entire body of
evidence will be presented in a standard ‘Risk of bias summary’ figure
(Higgins et al., 2011).
3.1.6. Synthesis of results
We will neither produce any summary measures, nor synthesise the
evidence quantitatively. The included evidence will be presented in
what could be described as an ‘evidence map’. All included data points
from included studies will be presented, together with meta-data on the
study design, number of participants, characteristics of population,
setting and exposure measurement of the data point.
3.1.7. Quality of evidence assessment
There is no agreed method for assessing quality of evidence in
systematic reviews of the prevalence of occupational and/or environ-
mental risk factors. We will adopt or adapt the latest Navigation Guide
instructions for grading (Lam et al., 2016c), including criteria (Ap-
pendix E). We will downgrade for the following five reasons from the
Grading of Recommendations Assessment, Development and Evaluation
(GRADE) approach: (i) risk of bias; (ii) inconsistency; (iii) indirectness;
(iv) imprecision; and (v) publication bias (Schünemann et al., 2011).
We will grade the evidence, using the three Navigation Guide quality of
evidence ratings: “high”, “moderate” and “low” (Lam et al., 2016c).
Within each of the relevant reasons for downgrading, we will rate any
concern per reason as “none”, “serious” or “very serious”. We will start
at “high” for non-randomized studies and will downgrade for no con-
cern by nil, for a serious concern by one grade (−1), and for a very
serious concern by two grades (−2). We will not up-grade or down-
grade the quality of evidence for the three other reasons normally
considered in GRADE assessments (i.e. large effect, dose-response and
plausible residual confounding and bias), because we consider them
irrelevant for prevalence estimates.
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All quality of evidence assessors (BA, TL, AM, MSP and RAR) will
trial the application of our instructions and criteria for quality of evi-
dence assessment until their understanding and application is syn-
chronized. Two separate review author groups (i.e. FG, AM, TT, and
MW and BA, TL, MSP, and RAR, respectively) will independently judge
the quality of evidence for the entire body of evidence by outcome. A
third review author group (CEP and SMJ) will resolve any conflicting
judgments. In the systematic review, for each outcome, we will present
our assessments of the risk for each GRADE domain, as well as an
overall GRADE rating.
3.1.8. Strength of evidence assessment
To our knowledge, no agreed method exists for rating strength of
evidence in systematic reviews of prevalence studies. We (SMJ, AM,
and MSP) will rate the strength of the evidence for use as input data for
estimating national-level exposure to the risk factor. Our rating will be
based on a combination of the following four criteria: (i) quality of the
entire body of evidence; (ii) population coverage of evidence (WHO
regions and countries); (iii) confidence in the entire body of evidence;
and (iv) other compelling attributes of the evidence that may influence
certainty. We will rate the strength of the evidence as either “poten-
tially sufficient” or “potentially inadequate” for use as input data
(Appendix F).
3.2. Systematic Review 2
3.2.1. Eligibility criteria
The PECO criteria (Liberati et al., 2009) are described below.
3.2.1.1. Types of populations. We will include studies of working-age
(≥15 years) workers in the formal and informal economy. Studies of
children (aged< 15 years) and unpaid domestic workers will be
excluded. Participants residing in any WHO and/or ILO Member State
and any industrial setting or occupation will be included. Appendix G
provides a complete, but briefer overview of the PECO criteria.
3.2.1.2. Types of exposures. We will include studies that define solar
UVR in accordance with our standard definition (Table 1). We will
include all studies where occupational exposure to solar UVR was
measured, whether objectively (e.g. by means of dosimeters) or
subjectively, including studies that used measurements by experts
(e.g. scientists with subject matter expertise) and self-reports by the
worker or workplace administrator or manager. If a study presents both
objective and subjective measurements, then we will prioritize
objective measurements. We will include studies with measures from
any data source, including registry data.
3.2.1.3. Types of comparators. The included comparator will be
participants exposed to the theoretical minimum risk exposure level
(Table 1). We will exclude all other comparators.
3.2.1.4. Types of outcomes. We will include studies that define cataract
in accordance with our standard definition of this outcome (see
‘Description of the outcome’).
The following measurements of cataract will be regarded as eligible:
i. Diagnosis by a physician.
ii. Hospital discharge record.
iii. Other relevant administrative data (e.g. record of sickness absence
or disability).
iv. Registry data of treatment for cataract.
All other measures will be excluded from this systematic review.
We will only include objective measures of cataract (e.g., diagnosed
or measured by an occupational health practitioner, such as an occu-
pational physician or nurse, using a validated tool) and exclude
subjective measures of the outcome (e.g. self-report by the worker).
3.2.1.5. Types of studies. We will include studies that investigate the
effect of occupational exposure to solar UVR on cataract for any years.
Eligible study designs will be randomized controlled trials (including
parallel-group, cluster, cross-over and factorial trials), cohort studies
(both prospective and retrospective), case-control studies and other
non-randomized intervention studies (including quasi-randomized
controlled trials, controlled before-after studies and interrupted time
series studies). We included a broader set of observational study designs
than is commonly included, because a recent augmented Cochrane
Review of complex interventions identified valuable additional studies
using such a broader set of study designs (Arditi et al., 2016). As we
have an interest in quantifying risk and not in qualitative assessment of
hazard (Barroga and Kojima, 2013), we will exclude all other study
designs (e.g. uncontrolled before-and-after, cross-sectional, qualitative,
modelling, case and non-original studies).
Records published in any year and any language will be included.
Again, the search will be conducted using English language terms, so
that records published in any language that present essential informa-
tion (i.e. title and abstract) in English will be included. If a record is
written in a language other than those spoken by the authors of this
review or those of other reviews in the series (Descatha et al., 2018;
Hulshof et al., for publication; Paulo et al., for publication; Li et al.,
2018; Mandrioli et al., 2018; Godderis et al., 2018; Rugulies et al.,
Accepted; Teixeira et al., for publication), then the record will be
translated into English. Published and unpublished studies will be in-
cluded.
Studies conducted using unethical practices will be excluded (e.g.,
RCTs that deliberately exposed humans to a known risk factor to human
health).
3.2.1.6. Types of effect measures. We will include measures of the
relative effect of occupational exposure to solar UVR on the risk of
having or developing cataracts, compared with the theoretical
minimum risk exposure level. In studies with low versus high
exposure, the risk estimate may be assessed based on risk estimated
in low versus high exposed workers. We will include relative effect
measures such as risk ratios and odds ratios for prevalence measures
and hazard ratios for incidence measures (e.g., developed cataract).
Measures of absolute effects (e.g. mean differences in risks or odds) will
be converted into relative effect measures, but if conversion is
impossible, they will be excluded. To ensure comparability of effect
estimates and facilitate meta-analysis, if a study presents an odds ratio,
then we will convert it into a risk ratio, if possible, using the guidance
provided in the Cochrane Collaboration's handbook for systematic
reviews of interventions (Higgins and Green, 2011).
As per our logic model (Fig. 1), we a priori consider the following
variables to be potential effect modifiers of the effect of solar UVR on
cataract: country, age, sex, socioeconomic position, industrial sector,
occupation, formality of economy and latitude. As mediating factors we
consider two groups of factors, affecting the exposure-outcome relation
through two different pathways, one related to work and one to per-
sonal factors.
If a study presents estimates for the effect from two or more alter-
native models that have been adjusted for different variables, then we
will systematically prioritize the estimate from the model that we
consider best adjusted, applying the lists of confounders and mediators
identified in our logic model (Fig. 1). We will prioritize estimates from
models adjusted for more potential confounders over those from models
adjusted for fewer. For example, if a study presents estimates from a
crude, unadjusted model (Model A), a model adjusted for one potential
confounder (Model B) and a model adjusted for two potential con-
founders (Model C), then we will prioritize the estimate from Model C.
We will prioritize estimates from models unadjusted for mediators over
those from models that adjusted for mediators, because adjustment for
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mediators can introduce bias. For example, if Model A has been ad-
justed for two confounders, and Model B has been adjusted for the same
two confounders and a potential mediator, then we will choose the
estimate from Model A over that from Model B. We prioritize estimates
from models that can adjust for time-varying confounders that are at
the same time also mediators, such as marginal structural models (Pega
et al., 2016), over estimates from models that can only adjust for time-
varying confounders, such as fixed-effects models (Gunasekara et al.,
2014), over estimates from models that cannot adjust for time-varying
confounding. If a study presents effect estimates from two or more
potentially eligible models, then we will explain specifically why we
prioritized the selected model.
3.2.2. Information sources and search
3.2.2.1. Electronic academic databases. At a minimum, we (AM and MP)
will search the four following electronic academic databases:
1. Ovid MEDLINE with Daily Update (1 January 1946 to 31 July
2018).
2. PubMed (1 January 1946 to 31 July 2018).
3. EMBASE (1 January 1947 to 31 July 2018).
4. Web of Science (1 January 1945 to 31 July 2018) with inclusion of
three databases: Science Citation Index Expanded; Social Sciences
Citation Index; and Arts and Humanities Citation Index.
The Ovid Medline search strategy for Systematic Review 2 is pre-
sented in Appendix H. We have tested and validated the search strategy
for the four selected databases. The International Clinical Trials
Register Platform, CISDOC and TOXNET databases were also tested, but
their scopes were found to not sufficiently cover that of the systematic
review. We will again perform searches in electronic databases oper-
ated in the English language using a search strategy in the English
language. We will adapt the search syntax to suit the other electronic
academic and grey literature databases. When we are nearing com-
pletion of the review, we will search the PubMed database for the most
recent publications (e.g., e-publications ahead of print) over the last six
months. Any deviation from the proposed search strategy in the actual
search strategy will be documented.
3.2.2.2. Electronic grey literature databases. At a minimum, we (AM and
MSP) will search the two following electronic grey literature databases:
1. OpenGrey (http://www.opengrey.eu/).
2. Grey Literature Report (http://greylit.org/).
3.2.2.3. Internet search engines. We (AM and MSP) will also search the
Google (www.google.com/) and GoogleScholar (www.google.com/
scholar/) Internet search engines and screen the first 100 hits for
potentially relevant records.
3.2.2.4. Organizational websites. The websites of the seven following
international organizations and national government departments will
be searched by AM and MSP:
1. International Labour Organization (www.ilo.org/).
2. World Health Organization (www.who.int).
3. European Agency for Safety and Health at Work (https://osha.
europa.eu/en).
4. Eurostat (www.ec.europa.eu/eurostat/web/main/home).
5. China National Knowledge Infrastructure (http://www.cnki.net/).
6. Finnish Institute of Occupational Health (https://www.ttl.fi/en/).
7. United States National Institute of Occupational Safety and Health
(NIOSH) of the United States of America, using the NIOSH data and
statistics gateway (https://www.cdc.gov/niosh/data/).
3.2.2.5. Hand-searching and expert consultation. We (AM and MSP) will
hand-search for potentially eligible studies in:
• Reference lists of previous systematic reviews.• Reference lists of all study records of all included studies.• Study records published over the past 24months in the three peer-
reviewed academic journals from which we obtain the largest
number of included studies.• Study records that have cited an included study record (identified in
Web of Science citation database).• Collections of the review authors.
Additional experts will be contacted with a list of included studies
and study records, with the request to identify potentially eligible ad-
ditional ones.
3.2.3. Study selection
Study selection will be carried out with Covidence (Babineau, 2014;
Covidence systematic review software). All study records identified in
the search will be downloaded, and duplicates will be identified and
deleted. Afterwards, at least two review authors (AM and MSP) will
independently screen against eligibility criteria titles and abstracts (step
1) and then full texts of potentially relevant records (step 2). A third
review author (CEP or TT) will resolve any disagreements between the
study selectors. If a study record identified in the literature search was
authored by a review author assigned to study selection or if an as-
signed review author was involved in the study, then the record will be
re-assigned to another review author for study selection. In the sys-
tematic review, we will document the study selection in a flow chart, as
per GATHER guidelines (Stevens et al., 2016).
3.2.4. Data extraction and data items
A data extraction form will be developed and trialled until data
extractors reach convergence and agreement. At a minimum, two re-
view authors (out of: AM, CEP, MSP and RAR) will extract data on study
characteristics (including study authors, study year, study country,
participants, exposure and outcome), study design (including summary
of study design, comparator, epidemiological models used and effect
estimate measure), risk of bias (including selection bias, reporting bias,
confounding and reverse causation) and study context. A third review
author (TL, TT or MW) will resolve conflicts in data extraction. Data
will be entered into and managed with the Review Manager, Version
5.3 (RevMan 5.3) (2014) or DistillerSR (EvidencePartner, 2017) soft-
wares, but the Health Assessment Workspace Collaborative (HAWC)
(Shapiro, 2015) may also be used in parallel or to prepare data for entry
into RevMan 5.3.
We will also extract data on potential conflict of interest in included
studies. For each author and affiliated organization of each included
study record, we will extract their financial disclosures and funding
sources. We will use a modification of a previous method to identify and
assess undisclosed financial interest of authors (Forsyth et al., 2014).
Where no financial disclosure or conflict of interest statements are
available, we will search the name of all authors in other study records
gathered for this study and published in the prior 36months and in
other publicly available declarations of interests (Drazen et al., 2010a;
Drazen et al., 2010b).
We will request missing data from the principal study author by
email or phone, using the contact details provided in the principal study
record. If we do not receive a positive response from the study author,
we will send follow-up emails twice, at two and four weeks.
3.2.5. Risk of bias assessment
Standard risk of bias tools does not exist for systematic reviews for
hazard identification in occupational and environmental health, nor for
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risk assessment. The five methods specifically developed for occupa-
tional and environmental health are for either or both hazard identifi-
cation and risk assessment, and they differ substantially in the types of
studies (randomized, observational and/or simulation studies) and data
(e.g. human, animal and/or in vitro) they seek to assess (Rooney et al.,
2016). However, all five methods, including the Navigation Guide (Lam
et al., 2016c), assess risk of bias in human studies similarly (Rooney
et al., 2016).
The Navigation Guide was specifically developed to translate the
rigor and transparency of systematic review methods applied in the
clinical sciences to the evidence stream and decision context of en-
vironmental health (Woodruff and Sutton, 2014), which includes
workplace environment exposures and associated health outcomes. The
guide is our overall organizing framework, and we will also apply its
risk of bias assessment method in Systematic Review 2. The Navigation
Guide risk of bias assessment method builds on the standard risk of bias
assessment methods of the Cochrane Collaboration (Higgins et al.,
2011) and the US Agency for Healthcare Research and Quality
(Viswanathan et al., 2008). Some further refinements of the Navigation
Guide method may be warranted (Goodman et al., 2017), but it has
been successfully applied in several completed and ongoing systematic
reviews (Johnson et al., 2016; Johnson et al., 2014; Koustas et al., 2014;
Lam et al., 2016a; Lam et al., 2014; Lam et al., 2017; Lam et al., 2016b;
Vesterinen et al., 2014). In our application of the Navigation Guide
method, we will draw heavily on one of its latest versions, as presented
in the protocol for an ongoing systematic review (Lam et al., 2016c).
Should a more suitable method become available, we may switch to it.
We will assess risk of bias on the individual study level and on the
body of evidence overall. The nine risk of bias domains included in the
Navigation Guide method for human studies are: (i) source population
representation; (ii) blinding; (iii) exposure assessment; (iv) outcome
assessment; (v) confounding; (vi) incomplete outcome data; (vii) se-
lective outcome reporting; (viii) conflict of interest; and (ix) other
sources of bias. While two of the earlier case studies of the Navigation
Guide did not utilize outcome assessment as a risk of bias domain for
studies of human data (Johnson et al., 2014; Koustas et al., 2014; Lam
et al., 2014; Vesterinen et al., 2014), all of the subsequent reviews have
included this domain (Johnson et al., 2016; Lam et al., 2016a; Lam
et al., 2017; Lam et al., 2016b; Lam et al., 2016c). Risk of bias or
confounding ratings will be: “low”; “probably low”; “probably high”;
“high” or “not applicable” (Lam et al., 2016c). To judge the risk of bias
in each domain, we will apply a priori instructions (Appendix I), which
we have adopted or adapted from an ongoing Navigation Guide sys-
tematic review (Lam et al., 2016c). For example, a study will be as-
sessed as carrying “low” risk of bias from source population re-
presentation, if we judge the source population to be described in
sufficient detail (including eligibility criteria, recruitment, enrollment,
participation and loss to follow up) and the distribution and char-
acteristics of the study sample to indicate minimal or no risk of selec-
tion effects. The risk of bias at study level will be determined by the
worst rating in any bias domain for any outcome. For example, if a
study is rated as “probably high” risk of bias in one domain for one
outcome and “low” risk of bias in all other domains for the outcome and
in all domains for all other outcomes, the study will be rated as having a
“probably high” risk of bias overall.
All risk of bias assessors (BA, RC, FG, TL, AM, MSP, CEP, RAR, TT
and MW) will jointly trial the application of the risk of bias criteria until
they have synchronized their understanding and application of these
criteria. At least two study authors (out of: BA, RC, FG, TL, AM, MSP,
RAR and TT) will independently judge the risk of bias for each study by
outcome. Where individual assessments differ, a third author (CEP or
MW) will resolve the conflict. In the systematic review, for each in-
cluded study, we will report our study-level risk of bias assessment by
domain in a standard ‘Risk of bias’ table (Higgins et al., 2011). For the
entire body of evidence, we will present the study-level risk of bias
assessments in a ‘Risk of bias summary’ figure (Higgins et al., 2011).
3.2.6. Synthesis of results
We will conduct meta-analyses separately for estimates of the effect
on prevalence and incidence. If we find two or more studies with an
eligible effect estimate, two or more review authors (out of: BA, TL, AM,
MSP and RAR) will independently investigate the clinical heterogeneity
of the studies in terms of types of studies, participants (including
country, sex, age and industrial sector or occupation), level of risk
factor exposure, comparator and outcomes. If we find that effect esti-
mates differ considerably by country, sex and/or age, or a combination
of these, then we will synthesise evidence for the relevant populations
defined by country, sex and/or age, or combination thereof. Differences
by country could include or be expanded to include differences by
country group (e.g. WHO region or World Bank income group). If we
find that effect estimates are clinically homogenous across countries,
sexes and age groups, then we will combine studies from all of these
populations into one pooled effect estimate that could be applied across
all combinations of countries, sexes and age groups in the WHO/ILO
joint methodology.
If we judge two or more studies for the relevant combination of
country, sex and age group, or combination thereof, to be sufficiently
clinically homogenous to potentially be combined quantitatively using
quantitative meta-analysis, then we will test the statistical hetero-
geneity of the studies using the I2 statistic (Figueroa, 2014). If two or
more clinically homogenous studies are found to be sufficiently
homogenous statistically to be combined in a meta-analysis, we will
pool the risk ratios of the studies in a quantitative meta-analysis, using
the inverse variance method with a random effects model to account for
cross-study heterogeneity (Figueroa, 2014). The meta-analysis will be
conducted in RevMan 5.3, but the data for entry into these programmes
may be prepared using another recognized statistical analysis pro-
gramme, such as Stata. We will neither quantitatively combine data
from studies with different designs (e.g. combining cohort studies with
case-controls studies), nor unadjusted and adjusted models. We will
only combine studies that we judge to have a minimum acceptable level
of adjustment for confounders. If quantitative synthesis is not feasible,
then we will synthesise the study findings narratively and identify the
estimates that we judged to be the highest quality evidence available.
3.2.7. Additional analyses
If we source micro-data on exposure, outcome and potential con-
founding variables, we may conduct meta-regressions to adjust opti-
mally for potential confounders.
If there is evidence for differences in effect estimates by country,
sex, age, industrial sector and/or occupation, or by a combination of
these variables, then we will conduct subgroup analyses by the relevant
variable or combination of variables, as feasible. Where both studies on
workers in the informal economy and in the formal economy are in-
cluded, then we will conduct sub-group analyses by formality of
economy. Findings of these subgroup analyses, if any, will be used as
parameters for estimating burden of disease specifically for relevant
populations defined by these variables. Where possible, we will also
conduct subgroup analyses by study design (e.g. randomized controlled
trials versus cohort studies versus case-control studies) and temporal
direction for case-control and cohort studies (i.e. retrospective versus
prospective). Subgroup analyses may also be conducted by different
levels of solar UV exposure (e.g. quartiles of exposure and lifetime ex-
posure in years) and specific types of cataract (e.g. cortical versus nu-
clear versus posterior sub-capsular).
We will perform sensitivity analyses that will include only studies
judged to be of “low” or “probably low” risk of bias from conflict of
interest; judged to be of “low” or “probably low” risk of bias; and with
documented or approximated ICD-10 diagnostic codes. For meta-ana-
lyses with I2≥ 75%, we may also conduct sensitivity analyses using
two alternative meta-analytic models, namely the inverse variance
heterogeneity (IVhet) (Doi et al., 2015a) and quality effects (QE) (Doi
et al., 2015b) models.
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3.2.8. Quality of evidence assessment
We will assess quality of evidence using a modified version of the
Navigation Guide (Woodruff and Sutton, 2014) quality of evidence as-
sessment tool (Lam et al., 2016c). The tool is based on the GRADE
approach (Schünemann et al., 2011) adapted specifically to systematic
reviews in occupational and environmental health (Morgan et al.,
2016). Should a more suitable method become available, we may
switch to it.
We will assess quality of evidence for the entire body of evidence by
outcome, with any disagreements resolved by a third review author. We
will adopt or adapt the latest Navigation Guide instructions (Appendix E)
for grading the quality of evidence (Lam et al., 2016c). We will
downgrade the quality of evidence for the following five GRADE rea-
sons: (i) risk of bias; (ii) inconsistency; (iii) indirectness; (iv) impreci-
sion; and (v) publication bias. If our systematic review includes ten or
more studies, we will generate a funnel plot to judge concerns on
publication bias. If it includes nine or fewer studies, we will judge the
risk of publication bias qualitatively. To assess risk of bias from selec-
tive reporting, protocols of included studies, if any, will be screened to
identify instances of selective reporting.
We will grade the evidence, using the three Navigation Guide stan-
dard quality of evidence ratings: “high”, “moderate” and “low” (Lam
et al., 2016c). Within each of the relevant domains, we will rate the
concern for the quality of evidence, using the ratings “none”, “serious”
and “very serious”. As per Navigation Guide, we will start at “high” for
randomized studies and “moderate” for observational studies. Quality
will be downgraded for no concern by nil grades (0), for a serious
concern by one grade (−1) and for a very serious concern by two
grades (−2). We will up-grade the quality of evidence for the following
other reasons: large effect, dose-response and plausible residual con-
founding and bias. For example, if we have a serious concern for risk of
bias in a body of evidence consisting of observational studies (−1), but
no other concerns, and there are no reasons for upgrading, then we will
downgrade its quality of evidence by one grade from “moderate” to
“low”.
3.2.9. Strength of evidence assessment
We will apply the standard Navigation Guide methods (Lam et al.,
2016a, 2016b, 2016c) to rate the strength of the evidence. The rating
will be based on a combination of four criteria: (i) quality of body of
evidence, (ii) direction of effect, (iii) confidence in effect and (iv) other
compelling attributes of the data that may influence certainty. The
ratings for strength of evidence for the effect of occupational solar UVR
on cataract will be “sufficient evidence of toxicity/harmfulness”, “lim-
ited evidence of toxicity/harmfulness”, “inadequate evidence of toxi-
city/harmfulness” and “evidence of lack of toxicity/harmfulness” (Ap-
pendix J).
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